Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T35445 | Target Info | |||
Target Name | Mothers against decapentaplegic homolog 3 (SMAD3) | ||||
Synonyms | TGF-beta response effector Smad3; Smad3; SMAD family member 3; SMAD 3; Mothers against DPP homolog 3; Mad3; MMad3; MADH3; MAD homolog 3; JV15-2; HSMAD3; HMAD-3 | ||||
Target Type | Preclinical Target | ||||
Gene Name | SMAD3 | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 9 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Affinity Capture-Western | [5] | |||
6 | Affinity Capture-Western | [6] | |||
7 | Reconstituted Complex | [7] | |||
8 | Reconstituted Complex | [8] | |||
9 | Reconstituted Complex | [5] | |||
10 | Reconstituted Complex | [9] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase SMURF2 (SMURF2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [10] | |||
2 | Affinity Capture-MS | [11] | |||
3 | Affinity Capture-Western | [12] | |||
4 | Affinity Capture-Western | [13] | |||
5 | Affinity Capture-Western | [14] | |||
6 | Reconstituted Complex | [15] | |||
7 | Yeast two hybrid | [15] | |||
8 | Yeast two hybrid | [14] | |||
Interacting Target Name | Histone acetyltransferase KAT2B (KAT2B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Spermidine acetyltransferase KAT2B; PCAF; P300/CBP-associated factor; P/CAF; Lysine acetyltransferase 2B; Histone acetyltransferase PCAF; Histone acetylase PCAF | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [16] | |||
2 | Affinity Capture-Western | [17] | |||
3 | Affinity Capture-Western | [18] | |||
4 | Reconstituted Complex | [7] | |||
Interacting Target Name | E3 ubiquitin-protein ligase NEDD4 (NEDD4) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Neural precursor cell expressed developmentally down-regulated protein 4; NEDD4-1; NEDD-4; KIAA0093; HECT-type E3 ubiquitin transferase NEDD4; Cell proliferation-inducing gene 53 protein | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Affinity Capture-Western | [20] | |||
3 | Protein-peptide | [20] | |||
4 | Reconstituted Complex | [20] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase NEDD4-like (NEDD4L) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NEDD4.2; NEDD4.2; RSP5; hNEDD4.2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Affinity Capture-Western | [22] | |||
3 | Affinity Capture-Western | [23] | |||
4 | Reconstituted Complex | [22] | |||
Interacting Protein Name | Breast cancer type 1 susceptibility protein (BRCA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BRCAI; BRCC1; BROVCA1; FANCS; IRIS; PNCA4; PPP1R53; PSCP; RNF53 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [24] | |||
2 | Affinity Capture-Western | [25] | |||
3 | Reconstituted Complex | [24] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase TRIM33 (TRIM33) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ECTO; PTC7; RFG7; TF1G; TIF1G; TIF1GAMMA; TIFGAMMA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [26] | |||
2 | Affinity Capture-Western | [27] | |||
3 | Reconstituted Complex | [22] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase SMURF1 (SMURF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Affinity Capture-Western | [28] | |||
3 | Yeast two hybrid | [29] | |||
Interacting Protein Name | WW domain-containing protein 1 (WWP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WW domain-containing protein 1; Tiul1; TGIF-interacting ubiquitin ligase 1; NEDD4-like E3 ubiquitin-protein ligase WWP1; HECT-type E3 ubiquitin transferase WWP1; Atrophin-1-interacting protein 5; AIP5 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Yeast two hybrid | [30] | |||
3 | Yeast two hybrid | [31] | |||
Adapter proteins | [+] 1 Adapter proteins | + | |||
Interacting Protein Name | Erbin (ERBIN) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ERBIN; HEL.S.78; LAP2 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [26] | |||
2 | Affinity Capture-MS | [11] | |||
3 | Affinity Capture-Western | [32] | |||
4 | Reconstituted Complex | [33] | |||
5 | Reconstituted Complex | [32] | |||
Carbon-nitrogen hydrolases | [+] 1 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [9] | |||
2 | Yeast two hybrid | [34] | |||
Isomerases | [+] 1 Isomerases | + | |||
Interacting Target Name | Rotamase Pin1 (PIN1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Prolyl isomerase Pin1; PPIase Pin1; Peptidyl-prolyl cis-trans isomerase Pin1; Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1; Peptidyl prolyl cis/trans isomerase Pin1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [35] | |||
2 | Affinity Capture-Western | [36] | |||
3 | Protein-peptide | [20] | |||
Kinases | [+] 3 Kinases | + | |||
Interacting Target Name | Cyclin-dependent kinase 4 (CDK4) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PSK-J3; Cell division protein kinase 4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [37] | |||
2 | Co-localization | [38] | |||
Interacting Target Name | Cyclin-dependent kinase 2 (CDK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIN3-associated protein; Sin3 associated polypeptide; P33 protein kinase; Cell division protein kinase 2; CDKN2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [37] | |||
2 | Co-localization | [38] | |||
Interacting Target Name | TGF-beta receptor type I (TGFBR1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Type I TGFbeta receptor kinase; Transforming growth factor-beta receptor type I; TGFR-1; TGF-beta type I receptor; TGF-beta receptor type-1; TbetaR-I; TbetaRI; SKR4; Serine/threonine-protein kinase receptor R4; ALK-5; ALK5; Activin receptor-like kinase 5; Activin A receptor type II-like protein kinase of 53kD | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [39] | |||
2 | Biochemical Activity | [40] | |||
Nuclear hormone receptors | [+] 1 Nuclear hormone receptors | + | |||
Interacting Target Name | Androgen receptor (AR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Testosterone receptor; Nuclear receptor subfamily 3 group C member 4; NR3C4; Dihydrotestosterone receptor; DHTR; Androgen receptor | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [41] | |||
2 | Affinity Capture-Western | [42] | |||
3 | Affinity Capture-Western | [43] | |||
4 | Reconstituted Complex | [41] | |||
5 | Reconstituted Complex | [42] | |||
6 | Reconstituted Complex | [43] | |||
Peptidases | [+] 3 Peptidases | + | |||
Interacting Protein Name | Ubiquitin carboxyl-terminal hydrolase 15 (USP15) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | UNPH.2; UNPH4 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [44] | |||
2 | Affinity Capture-Western | [45] | |||
3 | Reconstituted Complex | [44] | |||
Interacting Target Name | Ubiquitin C-terminal hydrolase UCH37 (UCHL5) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | UCH-L5; UCH37; Ubiquitin thioesterase L5; Ubiquitin carboxyl-terminal hydrolase isozyme L5; CGI-70; AD-019 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [46] | |||
2 | Reconstituted Complex | [47] | |||
Interacting Target Name | Herpesvirus ubiquitin-specific protease (HAUSP) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-specific-processing protease 7; Ubiquitin thioesterase 7; Ubiquitin carboxyl-terminal hydrolase 7; Herpesvirus-associated ubiquitin-specific protease; Deubiquitinating enzyme 7 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Yeast two hybrid | [48] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [49] | |||
2 | Co-localization | [50] | |||
3 | Reconstituted Complex | [49] | |||
Transcription regulators | [+] 15 Transcription regulators | + | |||
Interacting Protein Name | Mothers against decapentaplegic homolog 4 (SMAD4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DPC4; JIP; MADH4; MYHRS | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Affinity Capture-Western | [51] | |||
3 | Affinity Capture-Western | [52] | |||
4 | Affinity Capture-Western | [22] | |||
5 | Affinity Capture-Western | [23] | |||
6 | Affinity Capture-Western | [25] | |||
7 | Affinity Capture-Western | [4] | |||
8 | Affinity Capture-Western | [11] | |||
9 | Affinity Capture-Western | [53] | |||
10 | Affinity Capture-Western | [54] | |||
11 | Affinity Capture-Western | [39] | |||
12 | Affinity Capture-Western | [55] | |||
13 | Affinity Capture-Western | [56] | |||
14 | Affinity Capture-Western | [57] | |||
15 | Affinity Capture-Western | [58] | |||
16 | Affinity Capture-Western | [59] | |||
17 | Affinity Capture-Western | [60] | |||
18 | Affinity Capture-Western | [61] | |||
19 | Affinity Capture-Western | [62] | |||
20 | Affinity Capture-Western | [63] | |||
Interacting Protein Name | Ski oncogene (SKI) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SGS; SKV | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [64] | |||
2 | Affinity Capture-Western | [65] | |||
3 | Affinity Capture-Western | [6] | |||
4 | Reconstituted Complex | [66] | |||
5 | Reconstituted Complex | [67] | |||
6 | Reconstituted Complex | [9] | |||
7 | Reconstituted Complex | [34] | |||
8 | Reconstituted Complex | [68] | |||
9 | Reconstituted Complex | [69] | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [26] | |||
2 | Affinity Capture-Western | [70] | |||
3 | Affinity Capture-Western | [71] | |||
4 | Affinity Capture-Western | [72] | |||
5 | Affinity Capture-Western | [73] | |||
6 | Protein-peptide | [73] | |||
7 | Reconstituted Complex | [73] | |||
8 | Reconstituted Complex | [67] | |||
Interacting Protein Name | Mothers against decapentaplegic homolog 2 (SMAD2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | JV18; JV18.1; MADH2; MADR2; hMAD.2; hSMAD2 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [74] | |||
2 | Affinity Capture-MS | [75] | |||
3 | Affinity Capture-MS | [11] | |||
4 | Affinity Capture-Western | [39] | |||
5 | Affinity Capture-Western | [54] | |||
6 | Affinity Capture-Western | [55] | |||
7 | Yeast two hybrid | [76] | |||
Interacting Target Name | Transcription factor AP-1 (JUN) | Discontinued Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | V-jun avian sarcoma virus 17 oncogene homolog; Transcription factor AP-1; Proto-oncogene c-jun; P39; C-jun proto-oncogene; AP-1 transcription factor; AP1; Activator protein-1; Activator protein 1 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [77] | |||
2 | Affinity Capture-Western | [78] | |||
3 | Reconstituted Complex | [77] | |||
4 | Reconstituted Complex | [34] | |||
5 | Reconstituted Complex | [79] | |||
6 | Yeast two hybrid | [77] | |||
Interacting Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; MOP1; Member of PAS protein 1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1; Hypoxia inducible factor 1; HIF-1-alpha; HIF-1alpha; HIF1-alpha; HIF-1 alpha; HIF1 alpha; Class E basic helix-loop-helix protein 78; bHLHe78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [80] | |||
2 | Affinity Capture-Western | [81] | |||
3 | Co-localization | [81] | |||
4 | Reconstituted Complex | [81] | |||
5 | Yeast two hybrid | [80] | |||
Interacting Protein Name | Ski-like protein (SKIL) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SNO; SnoA; SnoI; SnoN | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [82] | |||
2 | Affinity Capture-Western | [65] | |||
3 | Affinity Capture-Western | [6] | |||
4 | Affinity Capture-Western | [83] | |||
5 | Reconstituted Complex | [34] | |||
Interacting Target Name | Transcription factor Sp1 (SP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSFP1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [84] | |||
2 | Affinity Capture-Western | [59] | |||
3 | Reconstituted Complex | [85] | |||
Interacting Target Name | Runt-related transcription factor 2 (RUNX2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SL3-3 enhancer factor 1 alpha A subunit; SL3/AKV core-binding factor alpha A subunit; Polyomavirus enhancer-binding protein 2 alpha Asubunit; Polyomavirus enhancer-binding protein 2 alpha A subunit; PEBP2-alpha A; PEBP2A; PEA2-alpha A; Osteoblast-specific transcription factor 2; OSF-2; OSF2; Oncogene AML-3; Core-binding factor subunit alpha-1; CBF-alpha-1; CBFA1; AML3; Acute myeloid leukemia 3 protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [86] | |||
2 | Affinity Capture-Western | [87] | |||
3 | Reconstituted Complex | [86] | |||
Interacting Target Name | Hypoxia-inducible factor 2 alpha (HIF-2A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PASD2; PAS domain-containing protein 2; MOP2; Member of PAS protein 2; Hypoxia-inducible factor 2-alpha; HLF; HIF-2-alpha; HIF2-alpha; HIF2A; HIF-1-alpha-like factor; EPAS-1; Endothelial PAS domain-containing protein 1; Class E basic helix-loop-helix protein 73; bHLHe73; Basic-helix-loop-helix-PAS protein MOP2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-localization | [88] | |||
2 | Yeast two hybrid | [29] | |||
Interacting Target Name | Cyclic-AMP-dependent transcription factor ATF-3 (ATF3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclic AMP-dependent transcription factor ATF-3; cAMP-dependent transcription factor ATF-3; Activating transcription factor 3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [89] | |||
2 | Reconstituted Complex | [90] | |||
Interacting Target Name | Zinc finger E-box-binding homeobox 2 (ZEB2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Zinc finger homeobox protein 1b; ZFX1B; ZFHX1B; SMADIP1; Smad-interacting protein 1; SIP1; KIAA0569; HRIHFB2411 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [91] | |||
2 | Yeast two hybrid | [29] | |||
Interacting Protein Name | Forkhead box protein O3 (FOXO3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AF6q21; FKHRL1; FKHRL1P2; FOXO2; FOXO3A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [53] | |||
2 | Co-localization | [92] | |||
Interacting Protein Name | Transcriptional repressor protein YY1 (YY1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DELTA; INO80S; NF.E1; UCRBP; YIN.YANG.1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Reconstituted Complex | [93] | |||
Interacting Protein Name | Mad-related protein 1 (SMAD1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transforming growth factor-beta-signaling protein 1; Smad1; SMAD family member 1; SMAD 1; Mothers against DPP homolog 1; Mothers against decapentaplegic homolog 1; Mad-related protein 1; MADR1; MADH1; MAD homolog 1; JV4-1; BSP-1; BSP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Yeast two hybrid | [76] | |||
Ubiquitin related proteins | [+] 1 Ubiquitin related proteins | + | |||
Interacting Target Name | NEDD4-like E3 ubiquitin-protein ligase WWP2 (WWP2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WW domain-containing protein 2; WW domaincontaining protein 2; NEDD4like E3 ubiquitinprotein ligaseWWP2; HECT-type E3 ubiquitin transferase WWP2; Atrophin-1-interacting protein 2; Atrophin1interacting protein 2; AIP2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Affinity Capture-Western | [94] | |||
3 | Yeast two hybrid | [31] | |||
Other proteins | [+] 4 Other proteins | + | |||
Interacting Protein Name | Zinc finger FYVE domain-containing protein 9 (ZFYVE9) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MADHIP; NSP; PPP1R173; SARA; SMADIP | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [74] | |||
2 | Affinity Capture-MS | [75] | |||
3 | Affinity Capture-MS | [11] | |||
4 | Affinity Capture-Western | [95] | |||
5 | Co-crystal Structure | [69] | |||
6 | Reconstituted Complex | [69] | |||
7 | Yeast two hybrid | [29] | |||
Interacting Protein Name | Inner nuclear membrane protein Man1 (LEMD3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MAN1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [74] | |||
2 | Affinity Capture-MS | [75] | |||
3 | Affinity Capture-MS | [11] | |||
4 | Reconstituted Complex | [22] | |||
Interacting Target Name | Enhancer of filamentation 1 (NEDD9) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-12; p105; Neural precursor cell expressed developmentally down-regulated protein 9; NEDD-9; hEF1; CRK-associated substrate-related protein; CASS2; CAS-L; CasL; Cas scaffolding protein family member 2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [96] | |||
2 | Reconstituted Complex | [97] | |||
3 | Yeast two hybrid | [96] | |||
Interacting Protein Name | SNW domain-containing protein 1 (SNW1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Bx42; NCOA.62; PRPF45; Prp45; SKIIP; SKIP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Yeast two hybrid | [98] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways. J Biol Chem. 2004 Jul 16;279(29):30474-9. | ||||
REF 2 | Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J. 2003 May 15;22(10):2453-62. | ||||
REF 3 | AMP-activated protein kinase inhibits TGF--induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300. J Cell Physiol. 2012 Mar;227(3):1081-9. | ||||
REF 4 | Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes. Hepatology. 2010 Sep;52(3):1033-45. | ||||
REF 5 | TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. Genes Dev. 1998 Jul 15;12(14):2114-9. | ||||
REF 6 | Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth fact... Arthritis Rheum. 2007 May;56(5):1694-705. | ||||
REF 7 | The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Nucleic Acids Res. 2000 Nov 1;28(21):4291-8. | ||||
REF 8 | Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem. 2005 Oct 21;280(42):35203-8. | ||||
REF 9 | c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem. 1999 Dec 3;274(49):35269-77. | ||||
REF 10 | TRAF4 promotes TGF- receptor signaling and drives breast cancer metastasis. Mol Cell. 2013 Sep 12;51(5):559-72. | ||||
REF 11 | Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1. J Cell Biochem. 2008 Oct 1;105(2):596-611. | ||||
REF 12 | Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1). Oncogene. 2004 Sep 9;23(41):6914-23. | ||||
REF 13 | Selective compounds enhance osteoblastic activity by targeting HECT domain of ubiquitin ligase Smurf1. Oncotarget. 2016 Jul 18;8(31):50521-50533. | ||||
REF 14 | Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):974-9. | ||||
REF 15 | Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem. 2000 Nov 24;275(47):36818-22. | ||||
REF 16 | Characterization of a novel transcriptionally active domain in the transforming growth factor beta-regulated Smad3 protein. Nucleic Acids Res. 2005 Jul 1;33(12):3708-21. | ||||
REF 17 | Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5. Genes Cells. 2004 Feb;9(2):143-51. | ||||
REF 18 | A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGF-mediated breast cancer cell migration and invasion. Breast Cancer Res. 2012 Sep 20;14(5):R127. | ||||
REF 19 | NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Biochem J. 2005 Mar 15;386(Pt 3):461-70. | ||||
REF 20 | A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev. 2011 Jun 15;25(12):1275-88. | ||||
REF 21 | Structural basis for the versatile interactions of Smad7 with regulator WW domains in TGF- Pathways. Structure. 2012 Oct 10;20(10):1726-36. | ||||
REF 22 | Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell. 2009 Nov 13;36(3):457-68. | ||||
REF 23 | Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor- (TGF-)/Smad Signaling. J Biol Chem. 2016 Jan 1;291(1):382-92. | ||||
REF 24 | TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage. Oncogene. 2005 Mar 31;24(14):2289-97. | ||||
REF 25 | BRCA1 interacts with Smad3 and regulates Smad3-mediated TGF-beta signaling during oxidative stress responses. PLoS One. 2009 Sep 21;4(9):e7091. | ||||
REF 26 | Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program. J Biol Chem. 2008 Jan 11;283(2):1146-55. | ||||
REF 27 | Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF--dependent cancer metastasis. J Clin Invest. 2014 Feb;124(2):564-79. | ||||
REF 28 | An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017 Aug 24;8(1):347. | ||||
REF 29 | Functional proteomics mapping of a human signaling pathway. Genome Res. 2004 Jul;14(7):1324-32. Validation Studies | ||||
REF 30 | A proteome-scale map of the human interactome network. Cell. 2014 Nov 20;159(5):1212-1226. | ||||
REF 31 | Widespread macromolecular interaction perturbations in human genetic disorders. Cell. 2015 Apr 23;161(3):647-660. | ||||
REF 32 | Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain. Mol Cell Biol. 2007 Sep;27(17):6183-94. | ||||
REF 33 | Identification of three novel Smad binding proteins involved in cell polarity. FEBS Lett. 2003 Mar 27;539(1-3):167-73. | ||||
REF 34 | An essential role for Mad homology domain 1 in the association of Smad3 with histone deacetylase activity*. J Biol Chem. 2001 Jun 22;276(25):22595-603. | ||||
REF 35 | Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins. J Biol Chem. 2009 Mar 6;284(10):6109-15. | ||||
REF 36 | Pin1 promotes transforming growth factor-beta-induced migration and invasion. J Biol Chem. 2010 Jan 15;285(3):1754-64. | ||||
REF 37 | Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature. 2004 Jul 8;430(6996):226-31. | ||||
REF 38 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 39 | Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science. 2003 Jan 24;299(5606):574-7. | ||||
REF 40 | Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization. Sci Signal. 2015 Apr 14;8(372):ra35. | ||||
REF 41 | SMAD3 represses androgen receptor-mediated transcription. Cancer Res. 2001 Mar 1;61(5):2112-8. | ||||
REF 42 | The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. J Biol Chem. 2002 Jan 11;277(2):1240-8. | ||||
REF 43 | Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem. 2002 Nov 15;277(46):43749-56. | ||||
REF 44 | USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol. 2011 Sep 25;13(11):1368-75. | ||||
REF 45 | USP15 stabilizes TGF- receptor I and promotes oncogenesis through the activation of TGF- signaling in glioblastoma. Nat Med. 2012 Feb 19;18(3):429-35. | ||||
REF 46 | Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGF-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis. Sci Rep. 2016 Sep 8;6:33116. | ||||
REF 47 | The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene. 2005 Dec 1;24(54):8080-4. | ||||
REF 48 | Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011 Oct 11;7:536. | ||||
REF 49 | Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell. 2003 May 2;113(3):301-14. | ||||
REF 50 | Differential regulation of the REG-proteasome pathway by p53/TGF- signalling and mutant p53 in cancer cells. Nat Commun. 2013;4:2667. | ||||
REF 51 | A component of the ARC/Mediator complex required for TGF beta/Nodal signalling. Nature. 2002 Aug 8;418(6898):641-6. | ||||
REF 52 | Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis. Exp Cell Res. 2005 Jul 1;307(1):231-46. | ||||
REF 53 | Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 2004 Apr 16;117(2):211-23. | ||||
REF 54 | TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 1997 Sep 1;16(17):5353-62. | ||||
REF 55 | Hyaluronan activates Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed. Oncotarget. 2017 Mar 21;8(12):19137-19155. | ||||
REF 56 | Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation. J Biol Chem. 1999 Apr 2;274(14):9431-41. | ||||
REF 57 | Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling. Cell. 2002 Nov 1;111(3):357-67. | ||||
REF 58 | Roles of pathway-specific and inhibitory Smads in activin receptor signaling. Mol Endocrinol. 1999 Jan;13(1):15-23. | ||||
REF 59 | Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem. 2001 Mar 9;276(10):6983-92. | ||||
REF 60 | Transforming growth factor-1 induces expression of human coagulation factor XII via Smad3 and JNK signaling pathways in human lung fibroblasts. J Biol Chem. 2010 Apr 9;285(15):11638-51. | ||||
REF 61 | Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. J Biol Chem. 2003 Oct 24;278(43):42569-77. | ||||
REF 62 | CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF- signaling. Oncogene. 2012 Dec 13;31(50):5123-31. | ||||
REF 63 | Structural basis of heteromeric smad protein assembly in TGF-beta signaling. Mol Cell. 2004 Sep 10;15(5):813-23. | ||||
REF 64 | Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling. J Biol Chem. 2003 Aug 29;278(35):32489-92. | ||||
REF 65 | Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN. J Biol Chem. 2003 Jan 3;278(1):531-6. | ||||
REF 66 | Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcri... J Biol Chem. 2003 Oct 3;278(40):38998-9005. | ||||
REF 67 | Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling. J Biol Chem. 2007 Apr 13;282(15):11365-76. | ||||
REF 68 | The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. J Biol Chem. 2003 Jul 11;278(28):26249-57. | ||||
REF 69 | Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control. Genes Dev. 2002 Aug 1;16(15):1950-63. | ||||
REF 70 | Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. J Biol Chem. 2005 Jun 24;280(25):24227-37. | ||||
REF 71 | Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation. J Biol Chem. 2009 Sep 4;284(36):23912-24. | ||||
REF 72 | Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial-mesenchymal transition in prostate cancer cell. Oncotarget. 2016 Oct 4;7(40):65553-65567. | ||||
REF 73 | Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP. Oncogene. 2005 Jun 2;24(24):3864-74. | ||||
REF 74 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 75 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 76 | Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol. 1997 May;17(5):2521-8. | ||||
REF 77 | Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature. 1998 Aug 27;394(6696):909-13. | ||||
REF 78 | Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation. J Biol Chem. 2000 Sep 29;275(39):30226-31. | ||||
REF 79 | Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4844-9. | ||||
REF 80 | A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads. J Mol Biol. 2004 Feb 6;336(1):9-24. | ||||
REF 81 | Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem. 2001 Oct 19;276(42):38527-35. | ||||
REF 82 | Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev. 2001 Nov 1;15(21):2822-36. | ||||
REF 83 | Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science. 1999 Oct 22;286(5440):771-4. | ||||
REF 84 | Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis. 2006 Dec;27(12):2392-401. | ||||
REF 85 | Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem. 2000 Sep 22;275(38):29244-56. | ||||
REF 86 | A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10549-54. | ||||
REF 87 | Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem. 1999 Oct 29;274(44):31577-82. | ||||
REF 88 | Opposite functions of HIF- isoforms in VEGF induction by TGF-1 under non-hypoxic conditions. Oncogene. 2011 Mar 10;30(10):1213-28. | ||||
REF 89 | ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells. J Cell Sci. 2010 Oct 15;123(Pt 20):3558-65. | ||||
REF 90 | A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell. 2003 Apr;11(4):915-26. | ||||
REF 91 | Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin. J Biol Chem. 2005 Oct 21;280(42):35477-89. | ||||
REF 92 | SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner. Am J Physiol Cell Physiol. 2014 Aug 1;307(3):C278-87. | ||||
REF 93 | Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation. Mol Cell Biol. 2003 Jul;23(13):4494-510. | ||||
REF 94 | Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGF signalling and EMT. Oncogene. 2011 May 26;30(21):2451-62. | ||||
REF 95 | Cytoplasmic PML function in TGF-beta signalling. Nature. 2004 Sep 9;431(7005):205-11. | ||||
REF 96 | A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1. EMBO J. 2000 Dec 15;19(24):6759-69. | ||||
REF 97 | Direct interaction between Smad3, APC10, CDH1 and HEF1 in proteasomal degradation of HEF1. BMC Cell Biol. 2004 May 16;5:20. | ||||
REF 98 | Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription. J Biol Chem. 2001 May 25;276(21):18243-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.